[HTML][HTML] Enhancing dendritic cell cancer vaccination: the synergy of immune checkpoint inhibitors in combined therapies
S Zanotta, D Galati, R De Filippi, A Pinto - International Journal of …, 2024 - mdpi.com
Dendritic cell (DC) cancer vaccines are a promising therapeutic approach, leveraging the
immune system to fight tumors. These vaccines utilize DCs' ability to present tumor …
immune system to fight tumors. These vaccines utilize DCs' ability to present tumor …
[HTML][HTML] Overcoming Resistance to Checkpoint Inhibitors with Combination Strategies in the Treatment of Non-Small Cell Lung Cancer
A Reyes, R Muddasani, E Massarelli - Cancers, 2024 - mdpi.com
Simple Summary Treatment options for lung cancer have greatly expanded in the last
decade. Immune checkpoint inhibitors for patients without driver mutations have become the …
decade. Immune checkpoint inhibitors for patients without driver mutations have become the …
Proteogenomics offers a novel avenue in neoantigen identification for cancer immunotherapy
Y Ren, Y Yue, X Li, S Weng, H Xu, L Liu… - International …, 2024 - Elsevier
Cancer neoantigens are tumor-specific non-synonymous mutant peptides that activate the
immune system to produce an anti-tumor response. Personalized cancer vaccines based on …
immune system to produce an anti-tumor response. Personalized cancer vaccines based on …
Exploring Cancer Immunotherapy and the Promise of Cancer Vaccine
P Ranawat, B Sharma, P Singh, T Kaur - Critical Developments in …, 2024 - igi-global.com
The goal of immunotherapy is to enhance the immune system by managing the
immunological-mediated microenvironment, which makes it possible for immune cells to …
immunological-mediated microenvironment, which makes it possible for immune cells to …
Neoantigen-Based Cancer Vaccines: Current Innovations, Challenges and Future Directions in Personalized Immunotherapy
S Ahmed, MS Mazhar, MF Shabbir - Cancer Immunology Connect, 2024 - scifiniti.com
The development of neoantigen-based cancer vaccines represents a breakthrough in
personalized immunotherapy due to their ability to elicit strong and effective tumor-specific …
personalized immunotherapy due to their ability to elicit strong and effective tumor-specific …
[PDF][PDF] The mechanistic modes of Targeting immunometabolism in cancer: An innovative strategy: A narrative review
KK Kaur, GN Allahbadia - 2024 - researchgate.net
Previously we had detailed different gynaecological cancers, inclusive of high grade serous
ovarian cancers (HGSOC), breast cancer (BC), Hepatocellular carcinoma (HCC), non small …
ovarian cancers (HGSOC), breast cancer (BC), Hepatocellular carcinoma (HCC), non small …